RxDoctor Payments Data

Bradley Gross, MD

Neurological Surgery · Pittsburgh, PANPI 1518130384

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 89.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $54,724 and has fallen 94.8% since, to $2,872 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$134,681in general payments, 2019–2025

Across 264 payments — averaging $510.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$120K
  • Microvention, Inc.$8K
  • Balt USA, LLC$3K
  • Stryker$1K
  • Silk Road Medical, Inc.$1K
  • Johnson & Johnson$588
  • plus $1K from 8 others
$886,139in research payments, 2019–2025

Across 26 payments — averaging $34,082 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$768K
  • Route 92 Medical, Inc.$70K
  • Stryker$46K
  • Viz.ai, Inc.$2K

What the payments were for

  • Consulting fees$31,64623%
  • Speaking & faculty fees$79,45059%
  • Travel & lodging$10,4918%
  • Food & beverage$13,07410%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134,681 in reported general payments places this provider in the 90th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$91,043
Medicare patients
108
Services billed
414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor13$7,025
ClopidogrelClopidogrel Bisulfate30$427
Prednisone11$10

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →